| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Circulating angiogenic factors and the risk of preeclampsia.
|
N Engl J Med
|
2004
|
14.00
|
|
2
|
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
|
N Engl J Med
|
2013
|
9.87
|
|
3
|
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
|
N Engl J Med
|
2008
|
9.19
|
|
4
|
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.
|
Kidney Int
|
2002
|
8.03
|
|
5
|
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
|
N Engl J Med
|
2006
|
7.06
|
|
6
|
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
|
N Engl J Med
|
2003
|
6.41
|
|
7
|
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.
|
Arch Intern Med
|
2007
|
5.26
|
|
8
|
Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
|
J Am Soc Nephrol
|
2005
|
4.44
|
|
9
|
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.
|
Mol Syst Biol
|
2008
|
3.82
|
|
10
|
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
|
J Am Soc Nephrol
|
2009
|
3.40
|
|
11
|
Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma.
|
Pediatrics
|
2010
|
3.39
|
|
12
|
Phosphorus binders and survival on hemodialysis.
|
J Am Soc Nephrol
|
2008
|
3.26
|
|
13
|
Impact of activated vitamin D and race on survival among hemodialysis patients.
|
J Am Soc Nephrol
|
2008
|
2.96
|
|
14
|
Effects of phosphate binders in moderate CKD.
|
J Am Soc Nephrol
|
2012
|
2.92
|
|
15
|
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
|
Hypertension
|
2007
|
2.77
|
|
16
|
Urinary placental growth factor and risk of preeclampsia.
|
JAMA
|
2005
|
2.76
|
|
17
|
Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship.
|
J Bone Miner Res
|
2011
|
2.55
|
|
18
|
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.
|
Am Heart J
|
2012
|
2.42
|
|
19
|
Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.
|
Clin Infect Dis
|
2009
|
2.34
|
|
20
|
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study.
|
Am J Epidemiol
|
2014
|
2.30
|
|
21
|
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.
|
Proc Natl Acad Sci U S A
|
2007
|
2.25
|
|
22
|
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.
|
Hypertens Pregnancy
|
2013
|
2.22
|
|
23
|
Early outcomes among those initiating chronic dialysis in the United States.
|
Clin J Am Soc Nephrol
|
2011
|
2.17
|
|
24
|
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study.
|
J Am Soc Nephrol
|
2005
|
2.04
|
|
25
|
Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry.
|
J Am Coll Cardiol
|
2004
|
2.03
|
|
26
|
Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.
|
Am J Obstet Gynecol
|
2005
|
2.03
|
|
27
|
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.
|
J Am Soc Nephrol
|
2009
|
1.95
|
|
28
|
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
|
Circulation
|
2012
|
1.88
|
|
29
|
Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality.
|
Circulation
|
2009
|
1.85
|
|
30
|
Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.
|
Kidney Int
|
2010
|
1.83
|
|
31
|
First trimester insulin resistance and subsequent preeclampsia: a prospective study.
|
J Clin Endocrinol Metab
|
2002
|
1.79
|
|
32
|
Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
|
Pediatr Res
|
2005
|
1.78
|
|
33
|
Ergocalciferol and cholecalciferol in CKD.
|
Am J Kidney Dis
|
2012
|
1.72
|
|
34
|
Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
|
J Am Soc Nephrol
|
2005
|
1.71
|
|
35
|
Postpartum diabetes screening in women with a history of gestational diabetes.
|
Obstet Gynecol
|
2005
|
1.70
|
|
36
|
Genetic variation in APOL1 associates with younger age at hemodialysis initiation.
|
J Am Soc Nephrol
|
2011
|
1.70
|
|
37
|
Metabolite profiling identifies markers of uremia.
|
J Am Soc Nephrol
|
2010
|
1.63
|
|
38
|
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
|
Hypertension
|
2007
|
1.56
|
|
39
|
Nutritional vitamin D in dialysis patients: what to D-iscern?
|
Nephrol Dial Transplant
|
2011
|
1.49
|
|
40
|
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.
|
Kidney Int
|
2013
|
1.48
|
|
41
|
Familial factors in the association between preeclampsia and later ESRD.
|
Clin J Am Soc Nephrol
|
2012
|
1.47
|
|
42
|
Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.
|
Clin J Am Soc Nephrol
|
2010
|
1.44
|
|
43
|
First-trimester C-reactive protein and subsequent gestational diabetes.
|
Diabetes Care
|
2003
|
1.41
|
|
44
|
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.
|
Hypertension
|
2010
|
1.39
|
|
45
|
Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults.
|
J Allergy Clin Immunol
|
2011
|
1.35
|
|
46
|
Pregnancy and the kidney.
|
J Am Soc Nephrol
|
2008
|
1.34
|
|
47
|
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.
|
J Clin Endocrinol Metab
|
2004
|
1.34
|
|
48
|
Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy.
|
Diabetes Care
|
2007
|
1.32
|
|
49
|
Moderate alcohol consumption and lower levels of inflammatory markers in US men and women.
|
Atherosclerosis
|
2005
|
1.30
|
|
50
|
Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
|
Am J Kidney Dis
|
2010
|
1.26
|
|
51
|
Clinical measures identify vitamin D deficiency in dialysis.
|
Clin J Am Soc Nephrol
|
2010
|
1.25
|
|
52
|
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.
|
Sci Transl Med
|
2013
|
1.25
|
|
53
|
1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.
|
J Immunol
|
2013
|
1.24
|
|
54
|
Trace elements in hemodialysis patients: a systematic review and meta-analysis.
|
BMC Med
|
2009
|
1.21
|
|
55
|
Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.21
|
|
56
|
Active vitamin D treatment for reduction of residual proteinuria: a systematic review.
|
J Am Soc Nephrol
|
2013
|
1.17
|
|
57
|
Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
|
J Am Soc Nephrol
|
2009
|
1.16
|
|
58
|
A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.
|
J Am Heart Assoc
|
2013
|
1.15
|
|
59
|
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI).
|
Contrib Nephrol
|
2013
|
1.11
|
|
60
|
Trace element status in hemodialysis patients.
|
Semin Dial
|
2010
|
1.10
|
|
61
|
Predicting gestational diabetes: choosing the optimal early serum marker.
|
Am J Obstet Gynecol
|
2007
|
1.09
|
|
62
|
Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats.
|
Am J Pathol
|
2010
|
1.09
|
|
63
|
Vitamin D-binding protein and vitamin D in blacks and whites.
|
N Engl J Med
|
2014
|
1.08
|
|
64
|
Kidney complications: why don't statins always work?
|
Nat Med
|
2010
|
1.05
|
|
65
|
An integrated approach to prognosis using protein microarrays and nonparametric methods.
|
Mol Syst Biol
|
2007
|
1.05
|
|
66
|
Statin use and calcific uremic arteriolopathy: a matched case-control study.
|
Am J Nephrol
|
2013
|
1.04
|
|
67
|
Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.
|
Cardiovasc Res
|
2011
|
1.04
|
|
68
|
Differential risk of hypertensive disorders of pregnancy among Hispanic women.
|
J Am Soc Nephrol
|
2004
|
1.03
|
|
69
|
1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.
|
Arch Biochem Biophys
|
2010
|
1.02
|
|
70
|
Klotho variants and chronic hemodialysis mortality.
|
J Bone Miner Res
|
2009
|
1.02
|
|
71
|
Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus.
|
Diabetes Care
|
2004
|
0.99
|
|
72
|
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes.
|
Kidney Int
|
2009
|
0.99
|
|
73
|
Vascular calcification and ESRD: a hard target.
|
Clin J Am Soc Nephrol
|
2009
|
0.99
|
|
74
|
Vitamin D receptor signaling inhibits atherosclerosis in mice.
|
Mol Endocrinol
|
2012
|
0.97
|
|
75
|
Risk for developing gestational diabetes in women with twin pregnancies.
|
J Matern Fetal Neonatal Med
|
2009
|
0.97
|
|
76
|
Optimizing a proteomics platform for urine biomarker discovery.
|
Mol Cell Proteomics
|
2010
|
0.96
|
|
77
|
Early pregnancy insulin resistance and subsequent gestational diabetes mellitus.
|
Diabetes Care
|
2005
|
0.94
|
|
78
|
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
|
Clin Chem
|
2008
|
0.93
|
|
79
|
Preeclampsia--a glimpse into the future?
|
N Engl J Med
|
2008
|
0.93
|
|
80
|
Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury.
|
Contrib Nephrol
|
2013
|
0.93
|
|
81
|
The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia.
|
Clin Chem
|
2012
|
0.92
|
|
82
|
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease.
|
PLoS One
|
2010
|
0.92
|
|
83
|
Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.
|
J Bone Miner Res
|
2010
|
0.91
|
|
84
|
Pathogenesis of preeclampsia.
|
Curr Opin Nephrol Hypertens
|
2015
|
0.90
|
|
85
|
Insulin resistance but not inflammation is associated with gestational hypertension.
|
Hypertension
|
2002
|
0.89
|
|
86
|
Diabetes and the kidney in pregnancy.
|
Semin Nephrol
|
2011
|
0.89
|
|
87
|
Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study.
|
Am J Kidney Dis
|
2013
|
0.88
|
|
88
|
New insights into uremia-induced alterations in metabolic pathways.
|
Curr Opin Nephrol Hypertens
|
2011
|
0.87
|
|
89
|
Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward.
|
J Steroid Biochem Mol Biol
|
2007
|
0.87
|
|
90
|
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease.
|
Clin Trials
|
2011
|
0.86
|
|
91
|
Vitamin D receptor and analogs.
|
Semin Nephrol
|
2004
|
0.86
|
|
92
|
Metabolomic profiling in the prediction of gestational diabetes mellitus.
|
Diabetologia
|
2015
|
0.85
|
|
93
|
VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system.
|
Mol Endocrinol
|
2013
|
0.85
|
|
94
|
Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain.
|
Matern Child Health J
|
2009
|
0.84
|
|
95
|
Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
|
Semin Dial
|
2005
|
0.83
|
|
96
|
A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.
|
Hemodial Int
|
2009
|
0.83
|
|
97
|
Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.
|
J Card Fail
|
2011
|
0.83
|
|
98
|
End-stage renal disease in patients with Fabry disease.
|
J Am Soc Nephrol
|
2002
|
0.83
|
|
99
|
Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.
|
J Genet Couns
|
2002
|
0.82
|
|
100
|
Dietary vitamin D intake in advanced CKD/ESRD.
|
Semin Dial
|
2010
|
0.82
|
|
101
|
Advances in the management of Anderson-Fabry disease: enzyme replacement therapy.
|
Expert Opin Biol Ther
|
2002
|
0.81
|
|
102
|
The potential role of plasma gelsolin in dialysis-related protein-energy wasting.
|
Blood Purif
|
2010
|
0.81
|
|
103
|
Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.
|
Nephrol Dial Transplant
|
2013
|
0.81
|
|
104
|
What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
|
Curr Opin Nephrol Hypertens
|
2013
|
0.80
|
|
105
|
Inching towards a targeted therapy for preeclampsia.
|
Hypertension
|
2009
|
0.80
|
|
106
|
Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications.
|
Am J Nephrol
|
2012
|
0.80
|
|
107
|
Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies.
|
Am J Obstet Gynecol
|
2010
|
0.79
|
|
108
|
Maternal angiogenic profile in pregnancies that remain normotensive.
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.79
|
|
109
|
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
|
Hypertens Pregnancy
|
2013
|
0.79
|
|
110
|
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia.
|
Prenat Diagn
|
2015
|
0.78
|
|
111
|
Fabry kidney disease.
|
Saudi J Kidney Dis Transpl
|
2007
|
0.78
|
|
112
|
Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
|
Hypertens Pregnancy
|
2014
|
0.77
|
|
113
|
Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis.
|
Am J Nephrol
|
2013
|
0.77
|
|
114
|
Vitamin D Therapy and Cardiac Function in Chronic Kidney Disease-Reply.
|
JAMA
|
2012
|
0.76
|
|
115
|
Preeclampsia and the risk of large-for-gestational-age infants.
|
Am J Obstet Gynecol
|
2011
|
0.76
|
|
116
|
Vitamin D deficiency: consequence or cause of CKD?
|
Clin J Am Soc Nephrol
|
2013
|
0.76
|
|
117
|
Low calcidiol levels and coronary artery calcification: true, true, and related?
|
J Am Soc Nephrol
|
2009
|
0.76
|
|
118
|
Levels of angiogenic factors in pregnancy and post-partum bleeding.
|
Acta Obstet Gynecol Scand
|
2008
|
0.76
|
|
119
|
A complement to kidney disease: CFHR5 nephropathy.
|
Lancet
|
2010
|
0.75
|
|
120
|
Fibroblast growth factor-23 and outcomes: new answers, new questions.
|
J Am Soc Nephrol
|
2013
|
0.75
|
|
121
|
Editorial: "Interfering" with preeclampsia.
|
Arthritis Rheumatol
|
2015
|
0.75
|
|
122
|
Enzyme therapy for Fabry's disease: registered for success?
|
Lancet
|
2009
|
0.75
|
|
123
|
Impact of new vitamin D data on future studies and treatment.
|
Curr Opin Nephrol Hypertens
|
2013
|
0.75
|
|
124
|
Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients.
|
BMC Nephrol
|
2011
|
0.75
|
|
125
|
Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients.
|
Am J Nephrol
|
2016
|
0.75
|
|
126
|
Association between altitude and mortality in incident dialysis patients.
|
JAMA
|
2009
|
0.75
|
|
127
|
Reply to "The role of fibroblast growth factor-23 in left atrial volume".
|
Am Heart J
|
2013
|
0.75
|
|
128
|
Welles et al. respond to "Low vitamin D and cardiovascular disease".
|
Am J Epidemiol
|
2014
|
0.75
|
|
129
|
Vitamin D therapy for chronic kidney disease.
|
Semin Nephrol
|
2009
|
0.75
|
|
130
|
Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis.
|
Obstet Gynecol
|
2017
|
0.75
|